AR
Akkisani Ravi Kumar Reddy
About Akkisani Ravi Kumar Reddy
Data last updated:
Akkisani Ravi Kumar Reddy is a Managing Director at Aura Research And Remedies Private Limited (since 2021), Managing Director at Stereo Drugs Private Limited (since 2022) and Designated Partner at Saraswathi Gopalam Memorial Hospital Llp (since 2026), and holds 1 more current directorship. The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.38 Cr; the largest is Aura Research And Remedies Private Limited at ₹4.36 Cr (FY 2025). Earlier, Akkisani Ravi Kumar Reddy was a Director at Khorana Biotech Private Limited (from 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 16 Mar 2021 | 2021 | ₹4.36 Cr (FY 2025) | Active | |
| Managing Director | 01 Dec 2022 | 2008 | ₹1.02 Cr (FY 2024) | Active | |
| Designated Partner | 29 Jul 2026 | 2026 | Active | ||
| Director | 16 Jul 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Nov 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Akkisani Ravi Kumar Reddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prathima Arveti | 10281036 | Aura Research And Remedies Private Limited , Stereo Drugs Private Limited | Director |
| Yerlampalli Sadananda Reddy Karthik | 11857957 | Saraswathi Gopalam Memorial Hospital Llp | Director/Designated Partner |
| Muniyappa Krishnamurthy | 11830193 | Si & C Resins Private Limited | Director |
| Varaprasadarao Nalamala | 11830194 | Si & C Resins Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akkisani Ravi Kumar Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akkisani Ravi Kumar Reddy
Akkisani Ravi Kumar Reddy currently holds 4 directorships: Aura Research And Remedies Private Limited (Managing Director, since 16 Mar 2021, revenue ₹4.36 Cr (FY 2025)); Stereo Drugs Private Limited (Managing Director, since 01 Dec 2022, revenue ₹1.02 Cr (FY 2024)); Saraswathi Gopalam Memorial Hospital Llp (Designated Partner, since 29 Jul 2026); Si & C Resins Private Limited (Director, since 16 Jul 2026).
Akkisani Ravi Kumar Reddy was first appointed on 15 Nov 2018 as Director at Khorana Biotech Private Limited. The most recent appointment on record is 29 Jul 2026 at Saraswathi Gopalam Memorial Hospital Llp.
The 2 current companies of Akkisani Ravi Kumar Reddy that report revenue have a combined latest revenue of ₹5.38 Cr: Aura Research And Remedies Private Limited ₹4.36 Cr (FY 2025); Stereo Drugs Private Limited ₹1.02 Cr (FY 2024).
Akkisani Ravi Kumar Reddy held 1 earlier board appointment: Khorana Biotech Private Limited (Director, from 15 Nov 2018).
The current boards of Akkisani Ravi Kumar Reddy's companies include Prathima Arveti (Aura Research And Remedies Private Limited), Yerlampalli Sadananda Reddy Karthik (Saraswathi Gopalam Memorial Hospital Llp), Muniyappa Krishnamurthy (Si & C Resins Private Limited), Varaprasadarao Nalamala (Si & C Resins Private Limited).